COMMUNIQUÉS West-GlobeNewswire

Share buy-back week 10/2019
11/03/2019
Announcement 11 March 2019 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 2/2019 Coloplast has initiated the second part of the share buy-back programme totalling [...]
Novo Nordisk A/S - Share repurchase programme
11/03/2019
Bagsværd, Denmark, 11 March 2019 - On 1 February 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]
Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University
11/03/2019
Groundbreaking GDF15 biomarker may be the first single examination to accurately predict disease progression NEW YORK, March 11, 2019 (GLOBE NEWSWIRE) -- Q BioMed Inc. ( QBIO ), a commercial stage biotechnology [...]
Progenics Pharmaceuticals Announces Presentation of Safety Data for AZEDRA® (iobenguane I 131) at the 2019 Endocrine Society (ENDO) Annual Meeting
11/03/2019
NEW YORK, March 11, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company developing innovative medicines and imaging analysis technology for targeting and treating cancer, today [...]
Caladrius Biosciences to Present at the Alliance for Regenerative Medicine 7th Annual Cell & Gene Therapy Investor Day
11/03/2019
BASKING RIDGE, N.J., March 11, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company committed to the [...]
Menlo Therapeutics to Present at the 31st Annual ROTH Conference
11/03/2019
REDWOOD CITY, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus (itch), [...]
Ultragenyx to Present at Upcoming Investor Conferences
11/03/2019
NOVATO, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases [...]
Cocrystal Pharma Announces Closing of Private Placement
11/03/2019
BOTHELL, WA, March 11, 2019 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, [...]
First patient dosed in a Phase 2 study with LiPlaCis in prostate cancer
11/03/2019
Press release Hoersholm, Denmark and Cambridge, MA, US, March 11, 2019 – Oncology Venture A/S (“OV” or “the Company”) today announced that the first patient has been dosed in a Phase 2 study with LiPlaCis ® in prostate [...]
Merus to Present at the Cowen & Co. 39th Annual Health Care Conference
11/03/2019
UTRECHT, Netherlands, March 11, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “we”, “our” or the “Company”), a clinical-stage immuno-oncology company developing Biclonics®, innovative full-length human [...]
Catalyst Pharmaceuticals to Hold Fourth Quarter Financial Results and Corporate Update Conference Call and Webcast on Tuesday, March 19th, 2019
11/03/2019
CORAL GABLES, Fla., March 11, 2019 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]
Alfardan Medical with Northwestern Medicine select Allscripts
11/03/2019
Allscripts first client in Qatar to provide first-of-its-kind ambulatory care services CHICAGO, March 11, 2019 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX) announced today that Alfardan Group , one of the leading [...]
Daré Bioscience receives notification of second award from the National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development for the development of Ovaprene®
11/03/2019
SAN DIEGO, March 11, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced that it received a second Notice of Award of $982,851, part of a grant providing [...]
Principia Biopharma Reacquires Rights to Oral Immunoproteasome Program
11/03/2019
-- Principia and AbbVie mutually agree to end collaboration -- -- Preclinical stage program focused on development of oral immunoproteasome inhibitors to treat inflammation and autoimmune disorders -- SOUTH SAN [...]
ProQR Doses First Patient in Phase 1/2 STELLAR Trial of QR-421a for Usher Syndrome Type 2
11/03/2019
LEIDEN, Netherlands and CAMBRIDGE, Mass., March 11, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the [...]
VBL Therapeutics to Present at the Society of Gynecologic Oncology (SGO) 50th Annual Meeting on Women's Cancer on March 18
11/03/2019
TEL AVIV, Israel, March 11, 2019 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]
Gritstone Oncology Announces the Appointment of Technology Executive, Mike Forcht, as Senior Vice President of Human Resources to Support Vision for Growth
11/03/2019
EMERYVILLE, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer [...]
Agile Therapeutics to Present at Upcoming Investor Conferences
11/03/2019
PRINCETON, N.J., March 11, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced today that its Senior Vice President and Chief Financial Officer, Scott Coiante will [...]
Eidos Therapeutics to Present at 31st Annual ROTH Conference
11/03/2019
SAN FRANCISCO, March 11, 2019 (GLOBE NEWSWIRE) -- Eidos Therapeutics , Inc. (Eidos) (Nasdaq:EIDX) today announced that management is scheduled to participate in a fireside chat regarding Eidos at the 31 st Annual ROTH [...]

Pages